New IP Bill will Enhance Legal Protection for Generic Drug Development
The Intellectual Property (Miscellaneous Provisions) Bill 2014, which is published today, will enhance the immunity from patent infringement for companies involved in testing generic versions of drugs while the original drugs continue to enjoy patent protection. A case in 1984
